CUSP Files FDA Citizen Petition to Protect Patients
Petition seeks to recall software that unfairly limits access to prescription drugs.
Barnes to Speak at 2023 Rx Summit
Michael C. Barnes, Esq., Principal Attorney at Sequel Legal, will speak and moderate in-person at the 2023 Rx Drug Abuse & Heroin Summit in Atlanta, Georgia.
CUSP Welcomes Distinguished Leaders to Its Board of Directors
Ronne Ostby, M.A.; LaTonya Pinkard, M.Ed.; and Marsha Stanton, Ph.D., R.N., have been elected to CUSP's board of directors.
Consumers Must Make Informed Decisions Regarding Cannabinoids
The Center for U.S. Policy’s chairman publishes an opinion piece in CONQUER Magazine.
There Is Another Drug Reform Bill the Senate Must Pass
CUSP’s chairman urges the U.S. Senate to pass S.3257, a bill to remove an unnecessary barrier to treatment for opioid use disorder.
Journal Seeks Articles on Innovative Opioid Policies
The Journal of Opioid Management has issued a call for articles for its special issue on opioid law and policy. Submissions are due January 30, 2023.
Individual Stories Underlie Addiction
Center for U.S. Policy Senior Fellow Lynn R. Webster, M.D shares his opinion on the Hulu series Dopesick.
Statement on Supreme Court Decision in Ruan v. U.S.
Center for U.S. Policy praises the Supreme Court’s decision, saying it will improve access to medically necessary treatments.
The Supreme Court Is About To Affect Every Prescriber in America
A question of criminal liability under the Controlled Substances Act is before the U.S. Supreme Court.
Guide for Decision Makers: Rx Digital Therapy Insurance Coverage
Center for U.S. Policy to co-host webinar on the advantages of providing health insurance coverage of prescription digital therapies.
